Screening compound: InChI=1S/C13H13N3O3/c17-13(16-4-6-18-7-5-16)11-8-12(19-15-11)10-2-1-3-14-9-10/h1-3,8-9H,4-7H2

Screening compound: InChI=1S/C13H13N3O3/c17-13(16-4-6-18-7-5-16)11-8-12(19-15-11)10-2-1-3-14-9-10/h1-3,8-9H,4-7H2
Screening compound: InChI=1S/C13H13N3O3/c17-13(16-4-6-18-7-5-16)11-8-12(19-15-11)10-2-1-3-14-9-10/h1-3,8-9H,4-7H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C13H13N3O3/c17-13(16-4-6-18-7-5-16)11-8-12(19-15-11)10-2-1-3-14-9-10/h1-3,8-9H,4-7H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C226-2084

Molecular Formula

C13H13N3O3 (C13 H13 N3 O3)

Compound Name

4-[5-(pyridin-3-yl)-1,2-oxazole-3-carbonyl]morpholine

IUPAC name

4-[5-(pyridin-3-yl)-12-oxazole-3-carbonyl]morpholine

SMILES

O=C(c1noc(-c2cnccc2)c1)N1CCOCC1

InChI

InChI=1S/C13H13N3O3/c17-13(16-4-6-18-7-5-16)11-8-12(19-15-11)10-2-1-3-14-9-10/h1-3,8-9H,4-7H2

InChI Key

DQHQCONYBKBRDG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09782615

InChI=1S/C13H13N3O3/c17-13(16-4-6-18-7-5-16)11-8-12(19-15-11)10-2-1-3-14-9-10/h1-3,8-9H,4-7H2 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Cardiovascular Library (22201 compounds)

Fragments Library (11262 compounds)

Targeted Diversity Library (40567 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cardiovascular
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Nervous system
  • Cardiovascular
Structure:
  • Fragments
Mechanism of action:
  • Epigenetic
Targets:
  • Ion Channels

References: we are preparing a list of scientific research reports with InChI=1S/C13H13N3O3/c17-13(16-4-6-18-7-5-16)11-8-12(19-15-11)10-2-1-3-14-9-10/h1-3,8-9H,4-7H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C13H13N3O3/c17-13(16-4-6-18-7-5-16)11-8-12(19-15-11)10-2-1-3-14-9-10/h1-3,8-9H,4-7H2?
Check Price and Availability of InChI=1S/C13H13N3O3/c17-13(16-4-6-18-7-5-16)11-8-12(19-15-11)10-2-1-3-14-9-10/h1-3,8-9H,4-7H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C13H13N3O3/c17-13(16-4-6-18-7-5-16)11-8-12(19-15-11)10-2-1-3-14-9-10/h1-3,8-9H,4-7H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C13H13N3O3/c17-13(16-4-6-18-7-5-16)11-8-12(19-15-11)10-2-1-3-14-9-10/h1-3,8-9H,4-7H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C13H13N3O3/c17-13(16-4-6-18-7-5-16)11-8-12(19-15-11)10-2-1-3-14-9-10/h1-3,8-9H,4-7H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C13H13N3O3/c17-13(16-4-6-18-7-5-16)11-8-12(19-15-11)10-2-1-3-14-9-10/h1-3,8-9H,4-7H2 available by request